##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H105-301222-ROCHE_S53_R
1	12793226	.	N	<DEL>	.	.	Type=Loss;Targets=17;Samples2=2;Span=99993;GeneNames=HNRNPCL1,LINC01784,PRAMEF1,PRAMEF2,PRAMEF4,PRAMEF10,PRAMEF11;GeneIDs=65121,105376745,440560,343069,65122,400735,343071;Genes=7;TranscriptNameClinicallyRelevant=NM_001013631.3,NR_146629.1,NM_023013.4,NM_023014.1,NM_001009611.4,NM_001039361.4,NM_001146344.3;OverlappingExonsClinicallyRelevant=All,All,2-4,All,All,4,All;HGVSg=NC_000001.11:g.12793226_12893218del;HGVScClinicallyRelevant=.,.,.,.,.,NM_001039361.4:c.1123_1425del,.;HGVSpClinicallyRelevant=.,.,.,.,.,NP_001034450.3:p.H375Gext?,.;ISCNCytobandNotation=del(1)p36.21;SequenceOntologyClinicallyRelevant=.,.,.,.,.,stop_lost,.;RegionClinicallyRelevant=.,.,.,.,.,exon,.;Region=1:12774425-12867713,1:12775725-12987188,1:12777697-12838021,1:12778589-13127227,1:12778601-12822941,1:12818031-12903935,1:12834668-12868975,1:12848979-12903944,1:12850124-12989284;Span2=93289,211464,60325,348639,44341,85905,34308,54966,139161;OverlapType=Partial Overlap,Within Region,Partial Overlap,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap;Name=gssvL888,gssvL883,gssvL896,gssvL880,gssvL902,gssvL891,gssvL905,gssvL894,gssvL886;Frequency=0.0215,0.0153,0.0197,0.0024,0.0002,0.0652,0.0927,0.0017,0.0155;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=1:12783555-12835547,1:12793717-12859204;Span3=51993,65488;OverlapType2=Partial Overlap,Contains Region;Type3=Deletion,Deletion;Frequency2=0.05,0.0364693;DeletionFrequency=0.05,0.0364693;DuplicationFrequency=0,0;END=12893218	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:112.374:-2.06722:0.587115:5.14955641990637e-12:HNRNPCL1,LINC01784,PRAMEF1,PRAMEF2,PRAMEF4,PRAMEF10,PRAMEF11::HNRNPCL1:NM_001013631.3:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46561inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
1	13164577	.	N	<DUP>	.	.	Type=Gain;Targets=13;Samples2=1;Span=61599;GeneNames=HNRNPCL4,PRAMEF9,PRAMEF13,PRAMEF18;GeneIDs=101060301,343070,400736,391003;Genes=4;TranscriptNameClinicallyRelevant=NM_001302551.2,NM_001010890.3,NM_001291380.1,NM_001099850.2;OverlappingExonsClinicallyRelevant=All,All,All,All;HGVSg=NC_000001.11:g.13164577_13226175dup;HGVScClinicallyRelevant=.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(1)p36.21;SequenceOntologyClinicallyRelevant=.,.,.,.;RegionClinicallyRelevant=.,.,.,.;Region2=1:13184701-13364099;Span3=179399;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00444444;DeletionFrequency=0;DuplicationFrequency=0.00444444;END=13226175	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:181.608:1.59847:1.90557:3.83036523571357e-06:HNRNPCL4,PRAMEF9,PRAMEF13,PRAMEF18::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps4proteincodinggenes:3
1	16988129	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=1871;GeneNames=ATP13A2;GeneIDs=23400;Aliases=CLN12,HSA9947,KRPPD,PARK9,SPG78;Genes=1;TranscriptNameClinicallyRelevant=NM_022089.4;OverlappingExonsClinicallyRelevant=22-25;HGVSg=NC_000001.11:g.16988129_16989999dup;HGVScClinicallyRelevant=NM_022089.4:c.2417_2859+9dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p36.13;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=16989999	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:114.003:3.41049:1.36822:2.05679521956716e-06:ATP13A2::ATP13A2:NM_022089.4:VUS:2L0ThiscnvpartiallyoverlapstheATP13A2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	21474884	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=120;GeneNames=NBPF3;GeneIDs=84224;Aliases=AE2;Genes=1;TranscriptNameClinicallyRelevant=NM_032264.6;OverlappingExonsClinicallyRelevant=8;HGVSg=NC_000001.11:g.21474884_21475003del;HGVScClinicallyRelevant=NM_032264.6:c.941-16_992+52del;HGVSpClinicallyRelevant=NP_115640.1:p.E314Gfs*43;ISCNCytobandNotation=del(1)p36.12;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=21475003	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-8.69996:0:2.1127987094817e-12:NBPF3::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:0
1	37946221	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=3;Span=120;GeneNames=INPP5B;GeneIDs=3633;Aliases=5PTase;Genes=1;TranscriptNameClinicallyRelevant=NM_005540.3;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000001.11:g.37946221_37946340dup;HGVScClinicallyRelevant=NM_005540.3:c.1_57+31dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)p34.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=37946340	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:94.9417:5.69382:1.82859:4.67835744595447e-06:INPP5B::INPP5B:NM_005540.3:VUS:2L0ThiscnvpartiallyoverlapstheINPP5Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	43322626	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=16953;GeneNames=MPL,TIE1;GeneIDs=7075,4352;Aliases=JTK14,LMPHM11,TIE;Genes=2;TranscriptNameClinicallyRelevant=NM_005373.3,NM_005424.5;OverlappingExonsClinicallyRelevant=1-4,23;HGVSg=NC_000001.11:g.43322626_43339578dup;HGVScClinicallyRelevant=NM_005373.3:c.1_690+9dup,NM_005424.5:c.3346-25_3417dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(1)p34.2;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=43339578	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:122.832:2.72901:1.30433:9.42749028297083e-07:MPL,TIE1::MPL:NM_005373.3:VUS:2L0ThiscnvpartiallyoverlapstheMPLgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	74706886	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=3371;GeneNames=CRYZ;GeneIDs=1429;Genes=1;TranscriptNameClinicallyRelevant=NM_001889.4;OverlappingExonsClinicallyRelevant=6-8;HGVSg=NC_000001.11:g.74706886_74710256dup;HGVScClinicallyRelevant=NM_001889.4:c.481-9_828+13dup;HGVSpClinicallyRelevant=NP_001880.2:p.V161_K276dup;ISCNCytobandNotation=dup(1)p31.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=74710256	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:69.0639:2.57161:1.52385:0.00036172403424817:CRYZ::CRYZ:NM_001889.4:VUS:2L0ThiscnvpartiallyoverlapstheCRYZgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	93110221	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=4;Span=424;GeneNames=MTF2;GeneIDs=22823;Aliases=M96,PCL2,TDRD19A,dJ976O13.2;Genes=1;TranscriptNameClinicallyRelevant=NM_007358.4;OverlappingExonsClinicallyRelevant=2-3;HGVSg=NC_000001.11:g.93110221_93110644dup;HGVScClinicallyRelevant=NM_007358.4:c.6-9_286+18dup;HGVSpClinicallyRelevant=NP_031384.1:p.G96Efs*27;ISCNCytobandNotation=dup(1)p22.1;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=93110644	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:128.376:3.45543:1.51525:8.83746401598302e-05:MTF2::MTF2:NM_007358.4:VUS:2L0ThiscnvpartiallyoverlapstheMTF2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	94188829	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=ARHGAP29;GeneIDs=9411;Aliases=PARG1;Genes=1;TranscriptNameClinicallyRelevant=NM_004815.4;OverlappingExonsClinicallyRelevant=15;HGVSg=NC_000001.11:g.94188829_94188948dup;HGVScClinicallyRelevant=NM_004815.4:c.1577-7_1681+8dup;HGVSpClinicallyRelevant=NP_004806.3:p.P527_G561dup;ISCNCytobandNotation=dup(1)p22.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=94188948	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.7:4.99748:1.85756:5.99741092741464e-05:ARHGAP29::ARHGAP29:NM_004815.4:VUS:2L0ThiscnvpartiallyoverlapstheARHGAP29genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	102912126	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=2;Span=120;GeneNames=COL11A1;GeneIDs=1301;Aliases=CO11A1,COLL6,DFNA37,STL2;Genes=1;TranscriptNameClinicallyRelevant=NM_001854.4;OverlappingExonsClinicallyRelevant=54;HGVSg=NC_000001.11:g.102912126_102912245dup;HGVScClinicallyRelevant=NM_001854.4:c.4033-33_4086+33dup;HGVSpClinicallyRelevant=NP_001845.3:p.P1349_G1366dup;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=102912245	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:86.675:7.74838:1.94128:4.24296647193063e-10:COL11A1::COL11A1:NM_001854.4:VUS:2L0ThiscnvpartiallyoverlapstheCOL11A1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	156158376	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=2186;GeneNames=SEMA4A;GeneIDs=64218;Aliases=CORD10,RP35,SEMAB,SEMB;Genes=1;TranscriptNameClinicallyRelevant=NM_022367.4;OverlappingExonsClinicallyRelevant=5-7;HGVSg=NC_000001.11:g.156158376_156160561dup;HGVScClinicallyRelevant=NM_022367.4:c.364-12_685+2dup;HGVSpClinicallyRelevant=NP_071762.2:p.D230Tfs*33;ISCNCytobandNotation=dup(1)q22;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=156160561	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:112.758:2.66193:1.364:0.000220798671017552:SEMA4A::SEMA4A:NM_022367.4:VUS:2L0ThiscnvpartiallyoverlapstheSEMA4Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	180989986	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=3469;GeneNames=STX6;GeneIDs=10228;Genes=1;TranscriptNameClinicallyRelevant=NM_005819.6;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000001.11:g.180989986_180993454dup;HGVScClinicallyRelevant=NM_005819.6:c.301-29_487dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(1)q25.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=180993454	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.658:3.12122:1.50253:0.00040671574483167:STX6::STX6:NM_005819.6:VUS:2L0ThiscnvpartiallyoverlapstheSTX6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	205061873	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=CNTN2;GeneIDs=6900;Aliases=AXT,FAME5,TAG-1,TAX,TAX1;Genes=1;TranscriptNameClinicallyRelevant=NM_005076.5;OverlappingExonsClinicallyRelevant=9;HGVSg=NC_000001.11:g.205061873_205061992dup;HGVScClinicallyRelevant=NM_005076.5:c.981_982ins(120);HGVSpClinicallyRelevant=NP_005067.1:p.E328_L367dup;ISCNCytobandNotation=dup(1)q32.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=205061992	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:142.408:5.07642:1.59188:4.56020332709433e-05:CNTN2::CNTN2:NM_005076.5:VUS:2L0ThiscnvpartiallyoverlapstheCNTN2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	89213706	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=4;Span=8621;END=89222326	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:228.131:4.8813:1.46257:9.57529011237675e-12:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,3A0Thiscnvoverlaps0proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
2	112021412	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=1160;GeneNames=MERTK;GeneIDs=10461;Aliases=MER,RP38,Tyro12,c-Eyk,c-mer;Genes=1;TranscriptNameClinicallyRelevant=NM_006343.3;OverlappingExonsClinicallyRelevant=17-18;HGVSg=NC_000002.12:g.112021412_112022571dup;HGVScClinicallyRelevant=NM_006343.3:c.2190-10_2486+177dup;HGVSpClinicallyRelevant=NP_006334.2:p.L731_L829dup;ISCNCytobandNotation=dup(2)q13;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=112022571	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:146.152:3.33407:1.3818:3.47909276658577e-06:MERTK::MERTK:NM_006343.3:VUS:2L0ThiscnvpartiallyoverlapstheMERTKgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	130173256	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=4;Span=450;GeneNames=SMPD4;GeneIDs=55627;Aliases=NEDMABA,NEDMEBA,NET13,NSMASE-3,NSMASE3,SKNY;Genes=1;TranscriptNameClinicallyRelevant=NM_017951.5;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000002.12:g.130173256_130173705dup;HGVScClinicallyRelevant=NM_017951.5:c.127-49_345+23dup;HGVSpClinicallyRelevant=NP_060421.3:p.E43_P115dup;ISCNCytobandNotation=dup(2)q21.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=130173705	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:132.828:2.91696:1.45152:5.04879447951522e-05:SMPD4::SMPD4:NM_017951.5:VUS:2L0ThiscnvpartiallyoverlapstheSMPD4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	240725277	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=KIF1A;GeneIDs=547;Aliases=ATSV,C2orf20,HSN2C,MRD9,NESCAVS,SPG30,UNC104;Genes=1;TranscriptNameClinicallyRelevant=NM_004321.8;OverlappingExonsClinicallyRelevant=38;HGVSg=NC_000002.12:g.240725277_240725396dup;HGVScClinicallyRelevant=NM_004321.8:c.3947_3948ins(120);HGVSpClinicallyRelevant=NP_004312.2:p.C1277_S1316dup;ISCNCytobandNotation=dup(2)q37.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=240725396	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:153.042:4.68263:1.62807:0.000172132995057865:KIF1A::KIF1A:NM_004321.8:VUS:2L0ThiscnvpartiallyoverlapstheKIF1Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	39107792	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=1418;GeneNames=TTC21A;GeneIDs=199223;Aliases=IFT139A,SPGF37,STI2,Thm2;Genes=1;TranscriptNameClinicallyRelevant=NM_001366900.1;OverlappingExonsClinicallyRelevant=1-2;HGVSg=NC_000003.12:g.39107792_39109209dup;HGVScClinicallyRelevant=NM_001366900.1:c.1_152dup;HGVSpClinicallyRelevant=NP_001353829.1:p.E52*;ISCNCytobandNotation=dup(3)p22.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=39109209	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:149.867:3.15117:1.37968:0.000356718444782095:TTC21A::TTC21A:NM_001366900.1:VUS:2L0ThiscnvpartiallyoverlapstheTTC21Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
3	101564772	.	N	<DUP>	.	.	Type=Gain;Targets=35;Samples2=1;Span=200788;GeneNames=CEP97,PCNP,PDCL3P4,RPL24,TRMT10C,ZBTB11,ZBTB11-AS1;GeneIDs=54931,57092,27107,100009676,6152,285359,79598;Aliases=COXPD30,HNYA,MRPP1,RG9MTD1;Genes=7;TranscriptNameClinicallyRelevant=NM_024548.4,NM_020357.3,NR_002941.2,NM_000986.4,NM_017819.4,NM_014415.4,NR_024407.1;OverlappingExonsClinicallyRelevant=All,All,All,All,2,All,All;HGVSg=NC_000003.12:g.101564772_101765559dup;HGVScClinicallyRelevant=.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.;ISCNCytobandNotation=dup(3)q12.3;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.;RegionClinicallyRelevant=.,.,.,.,.,.,.;END=101765559	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:180.83:3.55612:1.28505:1.55201636471585e-64:CEP97,PCNP,PDCL3P4,RPL24,TRMT10C,ZBTB11,ZBTB11-AS1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps5proteincodinggenes:3
3	130610621	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=COL6A6;GeneIDs=131873;Genes=1;TranscriptNameClinicallyRelevant=NM_001102608.3;OverlappingExonsClinicallyRelevant=23;HGVSg=NC_000003.12:g.130610621_130610740dup;HGVScClinicallyRelevant=NM_001102608.3:c.4753-28_4815+29dup;HGVSpClinicallyRelevant=NP_001096078.1:p.R1587_P1607dup;ISCNCytobandNotation=dup(3)q22.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=130610740	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:111.258:4.93177:1.62085:7.51168637947232e-05:COL6A6::COL6A6:NM_001102608.3:VUS:2L0ThiscnvpartiallyoverlapstheCOL6A6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	754988	.	N	<DUP>	.	.	Type=Gain;Targets=14;Samples2=1;Span=88735;GeneNames=ZDHHC11,ZDHHC11B;GeneIDs=653082,79844;Aliases=DHHC-11B;Genes=2;TranscriptNameClinicallyRelevant=NM_024786.3,NM_001351303.2;OverlappingExonsClinicallyRelevant=4-13,1-6;HGVSg=NC_000005.10:g.754988_843722dup;HGVScClinicallyRelevant=NM_024786.3:c.506_1239dup,NM_001351303.2:c.1_503+10dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(5)p15.33;SequenceOntologyClinicallyRelevant=3_prime_UTR_variant,transcript_ablation;RegionClinicallyRelevant=UTR3,exon;Region=5:595755-914240,5:667323-817865,5:710029-874903,5:722078-790474,5:722078-833513,5:763649-818543,5:772955-850986,5:772955-886860,5:795674-833513,5:824025-849806;Span2=318486,150543,164875,68397,111436,54895,78032,113906,37840,25782;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Name=gssvG29104,gssvG29111,gssvG29108,gssvG29125,gssvG29119,gssvG29131,gssvG29127,gssvG29115,gssvG29139,gssvG29144;Frequency=0.0084,0.0516,0.0529,0.0022,0.0068,0.0032,0.0011,0.0014,0.003,0.1275;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=5:673050-847204,5:741581-1021104,5:817736-874903,5:825530-843803;Span3=174155,279524,57168,18274;OverlapType2=Within Region,Within Region,Partial Overlap,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication;Frequency2=0.55,0.000168947,0.000337895,0.025;DeletionFrequency=0,0,0,0;DuplicationFrequency=0.55,0.000168947,0.000337895,0.025;END=843722	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:214.317:1.4261:1.34313:1.93262027849477e-05:ZDHHC11,ZDHHC11B::ZDHHC11:NM_024786.3:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46604inClinGenDosageSensitivitybutincludesadditionalmaterial.,2L0ThiscnvpartiallyoverlapstheZDHHC11genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
5	96912628	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=1;Span=4987;GeneNames=ERAP2;GeneIDs=64167;Aliases=L-RAP,LRAP;Genes=1;TranscriptNameClinicallyRelevant=NM_022350.5;OverlappingExonsClinicallyRelevant=16-19;HGVSg=NC_000005.10:g.96912628_96917614del;HGVScClinicallyRelevant=NM_022350.5:c.2355-9_2883del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(5)q15;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=5:96911798-96922208;Span2=10411;OverlapType=Within Region;Name=gssvL100830;Frequency=0.0016;Type2=Loss;Region2=5:96911908-96922016;Span3=10109;OverlapType2=Within Region;Type3=Deletion;Frequency2=0.00581395;DeletionFrequency=0.00581395;DuplicationFrequency=0;END=96917614	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:73.8341:-4.05412:0.568095:5.63004102690764e-11:ERAP2::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
6	32637440	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=5;Span=24887;GeneNames=HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1;GeneIDs=3117,3119,106480429;Aliases=CELIAC1,DQ-A1,DQA1,HLA-DQA;Genes=3;TranscriptNameClinicallyRelevant=NM_002122.5,NM_002123.5,NR_133907.1;OverlappingExonsClinicallyRelevant=All,3-5,All;HGVSg=NC_000006.12:g.32637440_32662326dup;HGVScClinicallyRelevant=.,NM_002123.5:c.380-78_786dup,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(6)p21.32;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.;RegionClinicallyRelevant=.,exon,.;Region=6:32632814-32696757,6:32633989-32668795,6:32635973-32730178,6:32636438-32660181,6:32644864-32658394;Span2=63944,34807,94206,23744,13531;OverlapType=Within Region,Within Region,Within Region,Partial Overlap,Contains Region;Name=gssvG32089,gssvG32094,gssvG32086,gssvG32105,gssvG32108;Frequency=0.2609,0.2647,0.0006,0.0216,0.034;Type2=Gain,Gain,Gain,Gain,Gain;Region2=6:32636539-32730648;Span3=94110;OverlapType2=Within Region;Type3=Duplication;Frequency2=0.625;DeletionFrequency=0;DuplicationFrequency=0.625;END=32662326	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:131.512:1.42583:1.42149:0.000314571958343016:HLA-DQA1,HLA-DQB1,HLA-DQB1-AS1::HLA-DQB1:NM_002123.5:Benign:2L0ThiscnvpartiallyoverlapstheHLA-DQB1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	138162070	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=3;Span=120;GeneNames=ARFGEF3;GeneIDs=57221;Aliases=A7322,BIG3,C6orf92,KIAA1244,PPP1R33,dJ171N11.1;Genes=1;TranscriptNameClinicallyRelevant=NM_020340.5;OverlappingExonsClinicallyRelevant=1;HGVSg=NC_000006.12:g.138162070_138162189dup;HGVScClinicallyRelevant=NM_020340.5:c.1_85+18dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(6)q23.3;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=138162189	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:138.408:4.52535:1.61963:0.000284861188050218:ARFGEF3::ARFGEF3:NM_020340.5:VUS:2L0ThiscnvpartiallyoverlapstheARFGEF3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	44258840	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=4254;GeneNames=CAMK2B;GeneIDs=816;Aliases=CAM2,CAMK2,CAMKB,CaMKIIbeta,MRD54;Genes=1;TranscriptNameClinicallyRelevant=NM_001220.5;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000007.14:g.44258840_44263093dup;HGVScClinicallyRelevant=NM_001220.5:c.161-29_275+32dup;HGVSpClinicallyRelevant=NP_001211.3:p.V93Sfs*46;ISCNCytobandNotation=dup(7)p13;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=44263093	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:136.192:3.57382:1.47609:4.97830043357762e-05:CAMK2B::CAMK2B:NM_001220.5:VUS:2L0ThiscnvpartiallyoverlapstheCAMK2Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	100875583	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=6231;GeneNames=SRRT;GeneIDs=51593;Aliases=ARS2,ASR2,serrate;Genes=1;TranscriptNameClinicallyRelevant=NM_015908.6;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000007.14:g.100875583_100881813dup;HGVScClinicallyRelevant=NM_015908.6:c.1_398+8dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(7)q22.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region2=7:100875266-100878569;Span3=3304;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=100881813	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:102.495:2.69697:1.35494:0.000181571792243559:SRRT::SRRT:NM_015908.6:VUS:2L0ThiscnvpartiallyoverlapstheSRRTgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	61410313	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=21022;GeneNames=TMEM26;GeneIDs=219623;Genes=1;TranscriptNameClinicallyRelevant=NM_178505.8;OverlappingExonsClinicallyRelevant=3-6;HGVSg=NC_000010.11:g.61410313_61431334dup;HGVScClinicallyRelevant=NM_178505.8:c.271-2_1107dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(10)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=61431334	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:183.261:3.44024:1.28132:5.92042934333422e-10:TMEM26::TMEM26:NM_178505.8:VUS:2L0ThiscnvpartiallyoverlapstheTMEM26genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
10	94820486	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=152;GeneNames=CYP2C19;GeneIDs=1557;Aliases=CPCJ,CYP2C,CYPIIC17,CYPIIC19,P450C2C,P450IIC19;Genes=1;TranscriptNameClinicallyRelevant=NM_000769.4;OverlappingExonsClinicallyRelevant=6;HGVSg=NC_000010.11:g.94820486_94820637dup;HGVScClinicallyRelevant=NM_000769.4:c.820-10_961dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(10)q23.33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=94820637	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:331.461:5.30885:1.67406:1.98988317519641e-05:CYP2C19::CYP2C19:NM_000769.4:VUS:2L0ThiscnvpartiallyoverlapstheCYP2C19genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	49637468	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=4558;GeneNames=FMNL3,PRPF40B;GeneIDs=25766,91010;Aliases=HYPC;Genes=2;TranscriptNameClinicallyRelevant=NM_175736.5,NM_001031698.3;OverlappingExonsClinicallyRelevant=26,17-19;HGVSg=NC_000012.12:g.49637468_49642025dup;HGVScClinicallyRelevant=.,NM_001031698.3:c.1561-2_1884+1dup;HGVSpClinicallyRelevant=.,NP_001026868.2:p.T521_S628dup;ISCNCytobandNotation=dup(12)q13.12;SequenceOntologyClinicallyRelevant=.,inframe_insertion;RegionClinicallyRelevant=.,exon;END=49642025	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:111.281:3.29205:1.38954:4.62291017451117e-06:FMNL3,PRPF40B::PRPF40B:NM_001031698.3:VUS:2L0ThiscnvpartiallyoverlapsthePRPF40Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
13	21155692	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=3;Span=16822;GeneNames=SKA3;GeneIDs=221150;Aliases=C13orf3,RAMA1;Genes=1;TranscriptNameClinicallyRelevant=NM_145061.6;OverlappingExonsClinicallyRelevant=3-8;HGVSg=NC_000013.11:g.21155692_21172513dup;HGVScClinicallyRelevant=NM_145061.6:c.166-9_1238+1dup;HGVSpClinicallyRelevant=NP_659498.4:p.*413Wext*21;ISCNCytobandNotation=dup(13)q12.11;SequenceOntologyClinicallyRelevant=stop_lost;RegionClinicallyRelevant=exon;END=21172513	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:175.771:2.03226:1.32181:6.63962817120716e-05:SKA3::SKA3:NM_145061.6:VUS:2L0ThiscnvpartiallyoverlapstheSKA3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	19747333	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=6;Span=189329;GeneNames=OR4K1,OR4K2,OR4K3,OR4K5,OR4M1,OR4N2,OR4Q3;GeneIDs=441669,441670,390429,283617,390431,79317,79544;Aliases=C14orf13,HSA6,OR14-3,OR4Q4,c14_5008;Genes=7;TranscriptNameClinicallyRelevant=NM_001004063.3,NM_001005501.2,NR_145507.2,NM_001005483.1,NM_001005500.2,NM_001004723.3,NM_172194.1;OverlappingExonsClinicallyRelevant=All,All,All,All,All,All,All;HGVSg=NC_000014.9:g.19747333_19936661dup;HGVScClinicallyRelevant=.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.;ISCNCytobandNotation=dup(14)q11.2;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.,.;RegionClinicallyRelevant=.,.,.,.,.,.,.;Region=14:19709051-19977459,14:19716201-19874569,14:19726341-19808815,14:19791588-19956892,14:19797476-19873135,14:19851530-19957689;Span2=268409,158369,82475,165305,75660,106160;OverlapType=Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Name=gssvG10817,gssvG10821,gssvG10829,gssvG10825,gssvG10838,gssvG10827;Frequency=0.0677,0.0004,0.0006,0.0009,0.0002,0.1048;Type2=Gain,Gain,Gain,Gain,Gain,Gain;Region2=14:19704993-19947632,14:19709052-19956594,14:19726698-19833781,14:19732025-19813305,14:19795943-19845066,14:19894662-19955213;Span3=242640,247543,107084,81281,49124,60552;OverlapType2=Within Region,Within Region,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.415273,0.531111,0.125,0.00101369,0.1,0.00118263;DeletionFrequency=0,0,0,0,0,0;DuplicationFrequency=0.415273,0.531111,0.125,0.00101369,0.1,0.00118263;END=19936661	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:391.623:1.78955:1.39009:1.68288704078143e-05:OR4K1,OR4K2,OR4K3,OR4K5,OR4M1,OR4N2,OR4Q3::OR4K1:NM_001004063.3:Benign:2D-1ThecnvissmallerthanthetriplobenignregionISCA-46679inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	23965752	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=5;Span=240;GeneNames=DHRS4;GeneIDs=10901;Aliases=CR,NRDR,PHCR,PSCD,SCAD-SRL,SDR-SRL,SDR25C1,SDR25C2;Genes=1;TranscriptNameClinicallyRelevant=NM_021004.4;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000014.9:g.23965752_23965991del;HGVScClinicallyRelevant=NM_021004.4:c.409-10_531+8del;HGVSpClinicallyRelevant=NP_066284.2:p.T137_P177del;ISCNCytobandNotation=del(14)q11.2;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;Region2=14:23965851-23965933;Span3=83;OverlapType2=Contains Region;Type3=Deletion;Frequency2=0.0781065;DeletionFrequency=0.0781065;DuplicationFrequency=0;END=23965991	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0.183333:-5.30335:0.00149441:1.92976276772488e-05:DHRS4::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:0
14	24000854	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=5;Span=240;GeneNames=DHRS4L2;GeneIDs=317749;Aliases=SDR25C3;Genes=1;TranscriptNameClinicallyRelevant=NM_198083.4;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000014.9:g.24000854_24001093dup;HGVScClinicallyRelevant=NM_198083.4:c.409-9_531+9dup;HGVSpClinicallyRelevant=NP_932349.2:p.T137_P177dup;ISCNCytobandNotation=dup(14)q11.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=24001093	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:327.446:5.61851:1.73406:6.25554385834841e-06:DHRS4L2::DHRS4L2:NM_198083.4:Benign:2L0ThiscnvpartiallyoverlapstheDHRS4L2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	11423157	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=3;Span=1196;GeneNames=LOC400499;GeneIDs=400499;Genes=1;TranscriptNameClinicallyRelevant=NM_001370704.1;OverlappingExonsClinicallyRelevant=40-42;HGVSg=NC_000016.10:g.11423157_11424352dup;HGVScClinicallyRelevant=NM_001370704.1:c.5909-8_6384+22dup;HGVSpClinicallyRelevant=NP_001357633.1:p.V2129Dfs*32;ISCNCytobandNotation=dup(16)p13.13;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=11424352	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:146.292:3.62723:1.36707:4.36415770030296e-07:LOC400499::LOC400499:NM_001370704.1:VUS:2L0ThiscnvpartiallyoverlapstheLOC400499genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	31397350	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=342;GeneNames=ITGAD;GeneIDs=3681;Aliases=ADB2,CD11D;Genes=1;TranscriptNameClinicallyRelevant=NM_005353.3;OverlappingExonsClinicallyRelevant=3-4;HGVSg=NC_000016.10:g.31397350_31397691dup;HGVScClinicallyRelevant=NM_005353.3:c.138-9_312+25dup;HGVSpClinicallyRelevant=NP_005344.2:p.A105Tfs*20;ISCNCytobandNotation=dup(16)p11.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=31397691	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:109.175:4.0819:1.56271:3.47722706739146e-06:ITGAD::ITGAD:NM_005353.3:VUS:2L0ThiscnvpartiallyoverlapstheITGADgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
16	57639328	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=ADGRG1;GeneIDs=9289;Aliases=BFPP,BPPR,GPR56,TM7LN4,TM7XN1;Genes=1;TranscriptNameClinicallyRelevant=NM_005682.7;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000016.10:g.57639328_57639447dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(16)q21;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=57639447	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:146.033:4.44896:1.73768:0.000361832534649159:ADGRG1::.:.:VUS:1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes,3A0Thiscnvoverlaps1proteincodinggenes:3
17	18229930	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=3;Span=2882;GeneNames=LLGL1;GeneIDs=3996;Aliases=HUGL,HUGL-1,HUGL1,LLGL,Lgl1,Mgl1;Genes=1;TranscriptNameClinicallyRelevant=NM_004140.4;OverlappingExonsClinicallyRelevant=2-4;HGVSg=NC_000017.11:g.18229930_18232811dup;HGVScClinicallyRelevant=NM_004140.4:c.82-11_392+9dup;HGVSpClinicallyRelevant=NP_004131.4:p.S131Rfs*58;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=18232811	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:143.4:3.45762:1.53639:8.74576067200495e-05:LLGL1::LLGL1:NM_004140.4:VUS:2B0WhiletheCNVoverlapstheLLGL1geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37418inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheLLGL1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	35153846	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=1796;GeneNames=FXYD5,FXYD7;GeneIDs=53822,53827;Genes=2;TranscriptNameClinicallyRelevant=NM_014164.6,NM_022006.2;OverlappingExonsClinicallyRelevant=1-2,6;HGVSg=NC_000019.10:g.35153846_35155641dup;HGVScClinicallyRelevant=NM_014164.6:c.1_61+30dup,NM_022006.2:c.221-48_243dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)q13.12;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=35155641	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:133.775:3.22718:1.41004:0.000254448836899705:FXYD5,FXYD7::FXYD5:NM_014164.6:VUS:2L0ThiscnvpartiallyoverlapstheFXYD5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	39892902	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=9945;GeneNames=FCGBP;GeneIDs=8857;Aliases=FC(GAMMA)BP;Genes=1;TranscriptNameClinicallyRelevant=NM_003890.2;OverlappingExonsClinicallyRelevant=16-21;HGVSg=NC_000019.10:g.39892902_39902846dup;HGVScClinicallyRelevant=NM_003890.2:c.4030-9_6495+9dup;HGVSpClinicallyRelevant=NP_003881.2:p.N1345_V2166dup;ISCNCytobandNotation=dup(19)q13.2;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;Region=19:39895410-39910403;Span2=14994;OverlapType=Partial Overlap;Name=gssvG19001;Frequency=0.0488;Type2=Gain;Region2=19:39871991-39921184,19:39872644-39919997,19:39883269-39899020,19:39892179-39899020,19:39895411-39910403,19:39899520-39902443,19:39899612-39901785;Span3=49194,47354,15752,6842,14993,2924,2174;OverlapType2=Within Region,Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.0222222,0.15,0.106509,0.00118343,0.025,0.00473373,0.00118343;DeletionFrequency=0,0,0,0,0,0,0;DuplicationFrequency=0.0222222,0.15,0.106509,0.00118343,0.025,0.00473373,0.00118343;END=39902846	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:270.551:2.50143:1.51895:8.55406761437088e-07:FCGBP::FCGBP:NM_003890.2:Benign:2L0ThiscnvpartiallyoverlapstheFCGBPgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	46120317	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=7;Span=4380;GeneNames=IGFL3;GeneIDs=388555;Aliases=UNQ483;Genes=1;TranscriptNameClinicallyRelevant=NM_207393.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000019.10:g.46120317_46124696del;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(19)q13.32;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=19:46118137-46125855;Span2=7719;OverlapType=Within Region;Name=gssvL58890;Frequency=0.0591;Type2=Loss;Region2=19:46119324-46125004,19:46119349-46124997,19:46119478-46125055,19:46120276-46127512;Span3=5681,5649,5578,7237;OverlapType2=Within Region,Within Region,Within Region,Within Region;Type3=Deletion,Deletion,Deletion,Deletion;Frequency2=0.135556,0.125,0.0502114,0.0295858;DeletionFrequency=0.135556,0.125,0.0502114,0.0295858;DuplicationFrequency=0,0,0,0;END=46124696	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:90.9528:-3.47389:0.558698:1.98911779364261e-08:IGFL3::IGFL3:NM_207393.2:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-46714inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:1
22	19883333	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=14812;GeneNames=TXNRD2;GeneIDs=10587;Aliases=GCCD5,SELZ,TR,TR-BETA,TR3,TRXR2;Genes=1;TranscriptNameClinicallyRelevant=NM_006440.5;OverlappingExonsClinicallyRelevant=10-12;HGVSg=NC_000022.11:g.19883333_19898144dup;HGVScClinicallyRelevant=NM_006440.5:c.683-14_1078dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(22)q11.21;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=19898144	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:120.213:2.55999:1.4029:0.000385039896409818:TXNRD2::TXNRD2:NM_006440.5:VUS:2B0WhiletheCNVoverlapstheTXNRD2geneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37433inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheTXNRD2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
22	35084382	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=7;Span=178085;GeneNames=HMGXB4,ISX,LINC01399;GeneIDs=91464,104310353,10042;Aliases=Pix-1,RAXLX;Genes=3;TranscriptNameClinicallyRelevant=NM_001003681.3,NM_001303508.2,NR_126356.1;OverlappingExonsClinicallyRelevant=1-2,4-5,All;HGVSg=NC_000022.11:g.35084382_35262466dup;HGVScClinicallyRelevant=NM_001003681.3:c.1_31+45dup,NM_001303508.2:c.382-1_738dup,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(22)q12.3;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.;RegionClinicallyRelevant=exon,exon,.;END=35262466	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:146.658:3.02891:1.36189:1.12437544249598e-06:HMGXB4,ISX,LINC01399::HMGXB4:NM_001003681.3:VUS:2L0ThiscnvpartiallyoverlapstheHMGXB4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
